Too low concentration of glycine was detected in the dried blood controls of the batch 2821 of the products.
Source facts
Action
The firm issued a recall notification on 05/19/2022 via email. The notification mentions if the consignee has used the affected product, check whether they have determined glycine, replace the old package insert with the updated package insert with release date 18.05.2022, forward a copy of the letter to another laboratory if the affected product was given to them, and submit the response form by 01.06.2022. If users determined glycine, they are asked to clarify with the attending physician or laboratory director, if necessary,
whether a back-check of the values for glycine is required.
Initiated
2022-05-19
Root cause
Labeling Change Control
Terminated
2024-05-15
Distribution
US: NY, OH, CT.
Recall number
Z-1337-2022
Recall status
Terminated
CDRH record ID
193987
FDA record created
2022-07-06
Recall event number
90266
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.